Abstract

Introduction: We report a rare case of non-insulin secreting malignant insulinoma of the pancreas and discuss its medical and surgical management.


Case Presentation: Our patient was a 62- year-old Persian female. Over the previous year, she had developed increased abdominal mass, dizziness, weakness, and fatigue. After surgical operation, chemotherapy was given to the patient. Treatment with cisplatin and etoposide was commenced in a 4-month course.


Conclusion: As a result, chemotherapy showed an important role in the management of insulinoma.

Keywords: Insulinoma Malignant Pancreas


Introduction

Pancreatic endocrine tumors (PETs), with mild to moderate malignancies, originate from pancreatic islets. The first case was detected in 1869 by Langerhans. These tumors are rare and the prevalence is 1-4 per million people 1,2. Among all, insulinoma is the most common type and can be seen mostly in people between the ages of 30- to 60-year-old 3,4.

Insulinoma accounts for only 1 percent of malignant pancreatic tumors and can occur with or without secretory function; and if it is combined with a hormonal syndrome, we considered it a secretory form 5. In non-secretory insulinoma, patients are asymptomatic until they develop gastric outlet obstruction or bile duct, or unless the tumor causes pain or are specified in imaging 6.

Case Presentation

A 62-year-old Persian female, who showed symptoms of headache, dizziness, fatigue and muscle jump about two years ago, had admitted in a hospital with a diagnosis of meningiomas and was operated to remove the mass.

Over the previous year, she had developed increased abdominal mass, dizziness, weakness, and fatigue. This time, since the early studies on suspicion of insulinoma secretary, a fasting test was performed according to protocol. At first, the blood samples were collected to check for glucose, insulin and C-peptide levels of patient, and then fasting was given to patient under close supervision. It was recommended to measure the patient's blood sugar in a serial form according to protocol if the symptoms of hypoglycemia persisted. Due to the normality of the test results, an abdominal Computed Tomography (CT) scan was requested to complete the studies. The CT scan showed a pancreatic tumor sized 13 x 8 mm along with extensive metastases to the surrounding area (Figure 1). For a definitive diagnosis, a needle biopsy and a pathologic examination were performed, and the malignant insulinoma diagnosis was confirmed. The dimension of the tumor was 6 × 5.8 × 13 mm.

Download figure
Enlarge figure
Figure 1 . Pancreatic tumor sized 13 × 8 mm along with extensive metastases to the surrounding area.

After surgical operation, chemotherapy was given to the patient. Treatment with cisplatin (I.V 170 mg/week) and etoposide (I.V 85 mg/daily) was commenced in a 4-month course. The current state of patient is acceptable and stable. Currently, the patient is under constant monitoring and care.

Discussion and Conclusions

Endocrine tumors comprise a small percentage (1-2%) of all pancreatic neoplasms. They are mostly seen in adults, but few cases have been reported in children and infants 7. Overall it is a rare tumor (with a prevalence of 1 in 250 million) and the annual incidence is 1 to 5 per million 8. 80% of cases were benign tumors and 40% of their size is below 1 cm 9,10.

In a previous study, mean duration of symptoms before diagnosis was less than 1.5 years 11. However, some patients may be asymptomatic for decades. Approximately 20% of patients are misdiagnosed with neurological or mental disorder before the diagnosis of insulinoma 12,13.

The results of non-invasive centralization techniques including ultrasonography, CT and magnetic resonance imaging (MRI) have been desponding, and sensitivities ranging from 0 to 33% have been reported 14. In the present case, detection with CT Scan and final approval with needle biopsy was performed.

PET treatments include two-part problem solving: problems related to secreted hormones, and problems related to tumor growth and metastasis. Chemotherapy is one of the treatment methods that shows good result in patients 15. In our case, according to the symptoms of abdominal pain and swelling, and no proof of secretory insulinoma, treatment with chemotherapy in the same regimen to small cell lung cancer based on CT Scan showed positive outcome. As a result, chemotherapy showed an important role in the management of insulinoma.

Abbreviations

CT: Computed tomography

PET: Pancreatic endocrine tumor

MRI: Magnetic resonance imaging

Competing Interests

The authors report no conflicts of interest in this work.

Authors' Contributions

MZ and MD followed this case and drafted the manuscript; MZ and MR helped for the follow up of this case; MZ, MD, and MR revised this paper. All authors read and approved the final manuscript.

References

  1. Pandey D., Sharma B., Kumar S., Chauhan V., Gupta D., Sharma A., Insulinoma Presenting with Psychiatric Symptoms. Journal Indian Academy of Clinical Medicine.. 2004; 5 (1) : 72-4 .
  2. Yao M.M., Reynertson R.H., Insulinoma: a case report and review of the clinical features and diagnosis. Gundersen Lutheran Medical Journal.. 2005; 3 : 73-6 .
  3. Lever-Rosas C.D., Enviquez-Pogan A., Chavaz-Rodrigue J.J., Galvan-Gonzalez J.L., Insulinoma- a case report. SevSanidMilitMex.. 2001; 55 : 170-3 .
  4. Mittendorf E.A., Liu Y.C., McHenry C.R., Giant insulinoma: case report and review of the literature. J Clin Endocrinol Metab. 2005; 90 (1) : 575-80 .
    View Article    PubMed    Google Scholar 
  5. Halder P.J., Hafeezunnisa P., Pai R., Samsi A.B., Insulinoma. J Postgrad Med. 1992; 38 (4) : 202-4 .
    PubMed    Google Scholar 
  6. Dizon A.M., Kowalyk S., Hoogwerf B.J., Neuroglycopenic and other symptoms in patients with insulinomas. Am J Med. 1999; 106 (3) : 307-10 .
    View Article    PubMed    Google Scholar 
  7. Juan R., Rosai and Ackerman's surgical pathologyMosby: New York; 2004.
    Google Scholar 
  8. Solcia E., Capella C., Kloppel G., Atlas of tumor pathologyArmed forces institute of pathology: Washington DC; 1997.
    Google Scholar 
  9. Schwartz S., Principles of surgerySaunders Co. 1999.
    Google Scholar 
  10. Correnti S., Intra operative ultrasonography for pancreatic InsulinomaMedline, Italy department of surgery 1996.
    Google Scholar 
  11. Service F.J., McMahon M.M., O'Brien P.C., Ballard D.J., Functioning insulinoma\textemdashincidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc. 1991; 66 (7) : 711-9 .
    View Article    PubMed    Google Scholar 
  12. Service F.J., Dale A.J., Elveback L.R., Jiang N.S., Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc. 1976; 51 (7) : 417-29 .
    PubMed    Google Scholar 
  13. Harrington M.G., McGeorge A.P., Ballantyne J.P., Beastall G., A prospective survey for insulinomas in a neurology department. Lancet. 1983; 1 (8333) : 1094-5 .
    View Article    PubMed    Google Scholar 
  14. Heerden J. Van, Pancreatic resection for carcinoma of the pancreas: whipples versus total pancreatectomy - an institutional perspective. World J Surg. 1994; 8 (6) .
    View Article    Google Scholar 
  15. Wong L.S., Hobbs S., Wright A.D., Dorricott N.J., A non-insulin secreting malignant insulinoma of the pancreas. Eur J Surg Oncol. 2000; 26 (3) : 314-6 .
    View Article    PubMed    Google Scholar 

Comments